PISCATAWAY, N.J., April 24, 2024 /PRNewswire/ -- Recently, GenScript Biotech Corporation (HK.1548),...
PISCATAWAY, N.J., April 15, 2024 /PRNewswire/ -- On April 15, GenScript Biotech Corporation ("GenSc...
R&D Innovation to Lead the Future, Deepening Customer Value Creation * Sustained High Revenue Gro...
SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial...
NANJING, China, Jan. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global leader in life science res...
NANJING, China, Jan. 4, 2024 /PRNewswire/ -- On January 10, 2024, the GenScript Biotech Global Foru...
NANJING, China, Dec. 24, 2023 /PRNewswire/ -- The innovative development of biopharmaceuticals has ...
Keynote speaker Peter Marks to Deliver Address Free Early Bird Registration Closing Soon NANJING,...
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the ...
Non-Cell Therapy Achieved 31.4% Adjusted Net Profit Growth Cell Therapy Business Revenue Surged By 7...
* Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, r...
* In the first half of 2021, the Group reported a revenue of approximately USD 229.6 million, a 3...
Strong Momentum across All Business Segments, particularly in Gene & Cell Therapy CDMO Continue to...
NANJING, China, Mar. 30, 2021 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548.HK) today h...
* Reported a revenue of approximately USD 390 million, a 42.9% YoY increase, and a gross profit o...
Highlights: * Revenue of the Group for the year ended December 31, 2020 was approximately ...
NANJING, China, Sept. 17, 2020 /PRNewswire/ -- On September 16th, 2020, GenScript ProBio and REMD B...
NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a lead...
SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Deve...
* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibo...
